Transepithelial transport of nanoparticles in oral drug delivery: From the perspective of surface and holistic property modulation

被引:13
|
作者
Zheng, Yaxian [1 ]
Luo, Shiqin [1 ]
Xu, Min [1 ]
He, Qin [1 ]
Xie, Jiang [1 ]
Wu, Jiawei [2 ]
Huang, Yuan [3 ,4 ]
机构
[1] Southwest Jiaotong Univ, Peoples Hosp Chengdu 3, Dept Pharm, Affiliated Hosp,Coll Med, Chengdu 610031, Peoples R China
[2] Univ Elect Sci & Technol China, Sichuan Acad Med Sci & Sichuan Prov Peoples Hosp, Personalized Drug Therapy Key Lab Sichuan Prov, Sch Med,Dept Pharm, Chengdu 610072, Peoples R China
[3] Sichuan Univ, Key Lab Drug Targeting & Drug Delivery Syst, Sichuan Engn Lab Plant Sourced Drug, Educ Minist & Sichuan Prov,West China Sch Pharm, Chengdu 610041, Peoples R China
[4] Sichuan Univ, Sichuan Res Ctr Drug Precis Ind Technol, West China Sch Pharm, Chengdu 610041, Peoples R China
基金
中国国家自然科学基金;
关键词
Oral delivery; Intestinal epithelial cells; Surface property; Holistic property; Transepithelial transport; MESOPOROUS SILICA NANOPARTICLES; INTESTINAL LYMPHATIC TRANSPORT; LIGAND-MODIFIED NANOPARTICLES; ENTERIC-COATED NANOPARTICLES; CELL-PENETRATING PEPTIDES; IN-VIVO; GOLD NANOPARTICLES; PROTEIN CORONA; PLGA NANOPARTICLES; BILE-ACID;
D O I
10.1016/j.apsb.2024.06.015
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Despite the promising prospects of nanoparticles in oral drug delivery, the process of oral administration involves a complex transportation pathway that includes cellular uptake, intracellular trafficking, and exocytosis by intestinal epithelial cells, which are necessary steps for nanoparticles to enter the bloodstream and exert therapeutic effects. Current researchers have identified several crucial factors that regulate the interaction between nanoparticles and intestinal epithelial cells, including surface properties such as ligand modification, surface charge, hydrophilicity/hydrophobicity, intestinal protein corona formation, as well as holistic properties like particle size, shape, and rigidity. Understanding these properties is essential for enhancing transepithelial transport efficiency and designing effective oral drug delivery systems. Therefore, this review provides a comprehensive overview of the surface and holistic properties that influence the transepithelial transport of nanoparticles, elucidating the underlying principles governing their impact on transepithelial transport. The review also outlines the chosen of parameters to be considered for the subsequent design of oral drug delivery systems. (C) 2024 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. This is an open access article under the CC BY -NC -ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:3876 / 3900
页数:25
相关论文
共 50 条
  • [21] Surface design of nanocarriers: Key to more efficient oral drug delivery systems
    Spleis, Helen
    Sandmeier, Matthias
    Claus, Victor
    Bernkop-Schnuerch, Andreas
    ADVANCES IN COLLOID AND INTERFACE SCIENCE, 2023, 313
  • [22] Surface modification of functional nanoparticles for controlled drug delivery
    Choi, SW
    Kim, WS
    Kim, JH
    JOURNAL OF DISPERSION SCIENCE AND TECHNOLOGY, 2003, 24 (3-4) : 475 - 487
  • [23] Relevance of Nanotechnology in Solving Oral Drug Delivery Challenges: A Perspective Review
    Dhadde, Shivsharan B.
    Patil, Jagadevappa S.
    Chandakavathe, Baburao N.
    Thippeswamy, B. S.
    Kavatekar, Mahantesh G.
    CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2020, 37 (05): : 407 - 434
  • [24] pH-sensitive dual drug loaded janus nanoparticles by oral delivery for multimodal analgesia
    Liu, Lin
    Yao, Wendong
    Xie, Xiaowei
    Gao, Jianqing
    Lu, Xiaoyang
    JOURNAL OF NANOBIOTECHNOLOGY, 2021, 19 (01)
  • [25] Recent advances in liposome surface modification for oral drug delivery
    Thanh Xuan Nguyen
    Huang, Lin
    Gauthier, Mario
    Yang, Guang
    Wang, Qun
    NANOMEDICINE, 2016, 11 (09) : 1169 - 1185
  • [26] Cyclodextrin/poly(anhydride) nanoparticles as drug carriers for the oral delivery of atovaquone
    Javier Calvo
    José Luis Lavandera
    Maite Agüeros
    Juan M. Irache
    Biomedical Microdevices, 2011, 13 : 1015 - 1025
  • [27] Enhanced Gut-to-Liver Oral Drug Delivery via Ligand-Modified Nanoparticles by Attenuating Protein Corona Adsorption
    Wang, Jie
    Zhang, Zilong
    Zhang, Zhuan
    Zou, Zhiwen
    Zhuo, Yan
    Liu, Chang
    Nie, Di
    Gan, Yong
    Yu, Miaorong
    ACS Nano, 2024, 18 (52) : 35310 - 35324
  • [28] Cyclodextrin/poly(anhydride) nanoparticles as drug carriers for the oral delivery of atovaquone
    Calvo, Javier
    Luis Lavandera, Jose
    Agueeros, Maite
    Irache, Juan M.
    BIOMEDICAL MICRODEVICES, 2011, 13 (06) : 1015 - 1025
  • [29] Inorganic nanoparticles for oral drug delivery: opportunities, barriers, and future perspectives
    Asad, Shno
    Jacobsen, Ann-Christin
    Teleki, Alexandra
    CURRENT OPINION IN CHEMICAL ENGINEERING, 2022, 38
  • [30] Stealth Amphotericin B nanoparticles for oral drug delivery: In vitro optimization
    AL-Quadeib, Bushra T.
    Radwan, Mahasen A.
    Siller, Lidija
    Horrocks, Benjamin
    Wright, Matthew C.
    SAUDI PHARMACEUTICAL JOURNAL, 2015, 23 (03) : 290 - 302